China’s lab monkey prices hit Covid-era highs on new drug R&D demand
A boom in China’s new drug research and development is driving laboratory monkey prices back to coronavirus pandemic-era highs, forcing some researchers to halt their studies. According to Guo…
Read the full article
Comments
Sign in to join the conversation.
No comments yet. Be the first.